F&G Annuities & Life (FG) is back in focus after first quarter results combined strong reported revenue and net income with a negative share price reaction, as non GAAP earnings missed analyst expectations.

That mixed reaction has fed into the share price, with FG now at $28.04 and showing a 1 month share price return of 3.43% but a year to date share price return that is down 6.66%. Over a longer horizon, the 3 year total shareholder return of 52.15% contrasts with a 1 year total shareholder return that is down 9.55%, suggesting recent momentum has faded even as long term holders remain ahead.

If this kind of earnings driven volatility has you thinking about diversification, it may be a moment to widen your search with 19 top founder-led companies

So, with first quarter revenue of US$1,187 million, net income of US$248 million and the stock sitting at US$28.04, is FG quietly undervalued here, or are markets already pricing in everything that comes next?

Most Popular Narrative: 3.9% Overvaluled

The most followed narrative currently pegs fair value for F&G Annuities & Life at $27, slightly below the last close at $28.04. This sets up a measured, earnings-led story rather than a deep discount argument.

Analysts have lowered their price target for F&G Annuities & Life from $37.43 to $27.00, citing updated assumptions that now combine a higher discount rate and sharply weaker revenue outlook with a stronger profit margin and a lower future P/E multiple.

Want to see what justifies a lower fair value with higher margins at the same time? The narrative leans on shifting revenue trajectories, sturdier profitability and a richer discount rate. It is worth understanding which of those inputs has the biggest weight in the 7.22% discount model.

The narrative uses a 7.22% discount rate and incorporates a revenue path that is expected to decline, alongside a higher net margin and a lower future P/E multiple, to arrive at its $27 fair value estimate. That combination points to a story where profitability assumptions do some of the heavy lifting while a weaker top line and lower valuation multiple keep the overall outcome in check.

Result: Fair Value of $27 (OVERVALUED)

However, this hinges on key assumptions, and pressure on MYGA volumes or margin compression from a competitive fixed portfolio could quickly challenge that fair value story.

Another View: Market Multiple Points to Value Support

While the SWS DCF model points to a fair value of $27, slightly below the current $28.04 share price, the earnings multiple tells a different story. FG trades on a P/E of 7.2x versus 12.3x for peers and 11.1x for the wider US Insurance industry. A fair ratio of 12.9x suggests the market could move closer to that level over time. For you, that gap raises a simple question: is this a warning the DCF is too cautious, or a sign that earnings risk is still underappreciated?

To see how the numbers stack up using this approach, review the valuation breakdown in the See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

If this mixed sentiment is leaving you undecided, take a closer look at the underlying data now and firm up your own stance with the 3 key rewards.

Looking for more investment ideas?

If FG has you thinking more broadly about where to put fresh capital to work, use this moment to scan the market for opportunities that better fit your goals.

• Target resilient cash generators by checking stocks that appear undervalued on quality and fundamentals with the 51 high quality undervalued stocks.
• Strengthen your income stream by reviewing companies offering robust payouts that feature in the 13 dividend fortresses.
• Prioritise financial stability by focusing on companies with sturdy balance sheets and fundamentals featured in the solid balance sheet and fundamentals stocks screener (45 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.